id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-280554-9jp85yzz	Lamure, Sylvain	Determinants of outcome in Covid-19 hospitalized patients with lymphoma: A retrospective multicentric cohort study	2020-10-13		.txt	text/plain	4536	225	48	The data obtained concerning lymphoma history included the date of diagnosis, pathological classification according to the WHO classification for lymphoid neoplasms [19] , number of treatment lines, past autologous or allogeneic stem cell transplant, chimeric antigen receptor (CAR) T-cell therapy, detailed bendamustine and anti-CD20 monoclonal antibody use (date of first and last administration), and lymphoma status at admission for Covid-19 (complete or partial remission, diagnosed at admission, under first or second line treatment, in watch and wait follow-up, or refractory/ relapsed). Covariates considered in this analysis were age ( 70 years versus below), gender, BMI ( 30 kg/m 2 versus below), smoking status, presence of comorbidities (overall or hypertension, diabetes, chronic lung disease, or past history of cancer) and ongoing antihypertensive treatment with an ACE inhibitor or angiotensin-receptor blocker (ARB), main lymphoma subtypes (Hodgkin lymphoma, B-cell non-Hodgkin lymphoma (NHL), or T-cell NHL), recent administration of corticosteroids (within one month), use of bendamustine (within one year), or anti-CD20 monoclonal antibody (within one year), time between diagnosis of lymphoma and hospitalization for Covid-19 (< 2 years versus 2 years), past history of autologous stem cell transplant, and lymphoma status (refractory/relapsed versus others).	./cache/cord-280554-9jp85yzz.txt	./txt/cord-280554-9jp85yzz.txt